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Abstract
Some pediatric rheumatologists in the West may take for granted that pediatric rheumatology (PR)
is a recognized subspecialty. Yet pediatric rheumatology has been accepted as a subspecialty in the
United States only since 1990. There are still countries where many pediatric subspecialties are not
given official recognition and support, including PR. This lack of recognition delays and impedes the
development of PR, appropriate musculoskeletal and rheumatic teaching in medical schools, and
optimal diagnosis and treatment for children with these illnesses. In the opinion of editorial staff,
each country where pediatric rheumatology is reasonably well developed as a subspecialty has an
obligation to help our pediatric rheumatologists elsewhere gain recognition, support, and respect.
The Pediatric Rheumatology European Society (PReS) and the Pediatric Rheumatology
International Trial Organization (PRINTO) have been leaders in this effort, but in many countries,
pediatric rheumatology is still not recognized. This editorial offers rationales and justifications for
medical and governmental entities accrediting pediatric rheumatology as a separate subspecialty
that may aid in these efforts.
Editorial
I am writing to you in support of an application of new
pediatric rheumatologists in your country to have their
subspecialty accredited by your governmental agency or
medical council and to receive governmental and univer-
sity support. I suggest to you that their application should
be approved in your country for the sake of children with
rheumatic disease.
I have five reasons for supporting their application for rec-
ognition as a pediatric subspecialty distinct from pediat-
rics and adult rheumatology:
1) Contrary to common belief, there are substantial num-
bers of children with rheumatic disease in your country
and around the world. The best prevalence figures are that
1–4/1000 children and adolescents have chronic arthritis
due to juvenile idiopathic arthritis. [1] For example, in a
country of 10 million, there are approximately 3 million
children; that translates into 5000 to 10,000 children with
chronic arthritis diseases including juvenile idiopathic
arthritis, lupus, dermatomyositis, sarcoidosis, and others.
Where are they? They are there but they are often invisible,
flying beneath the radar. They are often misdiagnosed
and/or slow to be diagnosed and treated. These diseases
do not often kill but they can cause much suffering and
disability, especially when not properly diagnosed and
treated. The cost to your society and gross national prod-
uct can be considerable. Yes, there are many competing
medical costs for children with malnutrition, diarrhea ill-
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nesses, HIV, tuberculosis, severe poverty, and other health
challenges. But children with arthritis illnesses also
deserve your help.
2) There are an inadequate number of pediatric rheuma-
tologists in your country and most countries for patient
care. By a recent guideline developed in the United King-
dom, a country such as yours needs one pediatric rheuma-
tologist per 300,000–500,000 population of children just
for clinical care. At a current population of 10 million,
from all available evidence, your country needs a mini-
mum of 6 pediatric rheumatologists to perform the neces-
sary clinical duties in the medical schools and medical
centers and would need an additional 6 to provide an
acceptable level of teaching and research in your medical
colleges, with at least one per medical college. To get to
this level of 12 pediatric rheumatologists or more in a
country of 10 million, we believe that at a minimum the
pediatric rheumatology subspecialty must be recognized.
It is optimal if a national center for pediatric rheumatol-
ogy be established with a training program to develop
new pediatric rheumatologists. It is our experience that
when pediatric rheumatology centers are not established,
these children are not properly diagnosed and treated.
3) Education about the medical musculoskeletal prob-
lems in children suffers without sufficient pediatric rheu-
matologists available to teach medical students and
residents and update pediatricians. The musculoskeletal
exam of children is underemphasized in medical schools
and resident training programs worldwide. In the UK a
study that reviewed the documentation of 257 admission
pediatric history and physicals noted that only 4% had a
musculoskeletal exam documented at all compared to
>90% for the lung and heart. [2] Time and time again, we
have noted that without a pediatric rheumatologist, no
one provides an education on non-surgical musculoskele-
tal conditions (not even orthopedists). Young physicians
may finish training with minimal exposure to these mus-
culoskeletal and rheumatic diseases in kids and how to
diagnose them, to the great disadvantage of children. It
should be noted that 6% of pediatric practice outpatient
visits may involve musculoskeletal pain problems [3] Pri-
mary care physicians who have not had training in a
screening musculoskeletal exam such as pGALS are likely
at a disadvantage. [4]
These concerns are not limited to pediatrics. Several stud-
ies have shown major deficiencies in the knowledge of
musculoskeletal medicine and the musculoskeletal exam-
ination in the United States and there is no reason to
believe that the musculoskeletal education is better else-
where. [5,6] The American Association of Medical Col-
leges has urged medical colleges to develop a longitudinal
educational program in musculoskeletal medicine
through all years of medical school. [7] As noted by the
World Health Organization in 2003, despite its low pro-
file due to a minimal mortality rate, "musculoskeletal or
rheumatic diseases are the major cause of morbidity
throughout the world, having a substantial influence on
health and quality of life, and inflicting an enormous bur-
den on health systems." [8]
4) Adult rheumatologists or skilled general pediatricians
are not the answer to fill this gap in education and patient
care. Adult rheumatologists are internists and have lim-
ited training in caring for children and adolescents with
rheumatic diseases; many have only one month of experi-
ence with children with musculoskeletal and rheumatic
diseases in training, if that or are trying to learn by doing.
They are often too busy caring for and teaching about
adult rheumatic problems to focus on caring for kids and
teaching about pediatric arthritis. They may consider
pediatric rheumatic diseases to be very similar to the adult
rheumatic diseases. Yet, in the view of many pediatric
rheumatologists, pediatric rheumatic diseases and mim-
icking diseases are often quite different than those seen in
adults (e.g., juvenile idiopathic arthritis, juvenile dermat-
omyositis, local scleroderma, Henoch-Schonlein purpura,
periodic fever syndromes, juvenile sarcoidosis under age
10 years, Kawasaki disease, neonatal lupus, genetic skele-
tal diseases, metabolic diseases, malignancies) than dis-
eases that are similar or identical (e.g., lupus, RF+
polyarticular JRA, systemic vasculitis, systemic sclerosis,
sarcoidosis over 10 years of age).
There are also multiple pediatric issues that internists tend
to have limited understanding of such as pain in children,
use of anti-rheumatic drugs in children, the art of dealing
with parents, school problems, transition into adulthood,
and others. Unless the adult rheumatologist decides to
increase his pediatric patients to 25% of his practice, he/
she will not develop the expertise needed to provide
standard of practice care and be able to maintain compe-
tency over a medical career.
True, there will never be prospective studies that validate
that the quality of care given by pediatric rheumatologists
is better. In my opinion, there is no need. It is self-evident
in the growth of pediatric rheumatology and other pediat-
ric subspecialties. In the end it comes down to who would
you or other parents want to care for your child with
arthritis, a pediatrician who does pediatric rheumatology
more than 50% of the time, often 100% of the time, or an
internist who sees only 5–10% children? Granted, there
are areas of each country where the only rheumatologist
available is an adult rheumatologist and their help is
essential and appreciated-yet that is a stop-gap solution
and development of pediatric rheumatology in every
country is the only acceptable long term solution.Publish with BioMed Central    and   every 
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General pediatricians have much to know about many
diseases. It is difficult for a primary care physician to
become competent in diagnosing and managing these
children with rheumatic disease unless he or she takes a
1–3 year pediatric rheumatology fellowship or learns the
hard way by gradually seeing more and more patients
until they represent >25% of the physician's practice. The
primary care physician would need to seek continuing
medical education at rheumatology meetings. This road
has been followed by many pioneers in pediatric rheuma-
tology and is being followed even now in some countries,
but it is a difficult road, requiring time, effort, funding,
and local support.
Finally, who educates the medical students and residents
as well as practicing pediatricians and family physicians if
there are no pediatric rheumatologists? Adult rheumatol-
ogists often have their own educational duties to teach
internists about adult arthritis and do not dependably
teach pediatricians and other child health care providers.
Similarly, generalist pediatricians may often have higher
priority educational areas to emphasize in their teaching
programs and efforts.
5) The key to providing care for these children is develop-
ing the pediatric rheumatology (PR) subspecialty by rec-
ognition of PR as a legitimate subspecialty. This has
already occurred in the US, Canada, and the UK and is
happening now in Europe and Asia. But progress is too
slow. In the US there are now 237 American Board of
pediatric-certified pediatric rheumatologists and there has
been a certification board exam available since 1992.
Growth is not easy but it is speeding up. [9] For the benefit
of the children, we need more pediatric rheumatologists
in many other countries. We believe recognition of pedi-
atric rheumatology is critical. A recent United States gov-
ernment study documented the immediate need for an
increase of 30% pediatric rheumatology workforce in the
US. The study provides excellent justification for support
for this field in the US and in every country. [10] The peril
of not providing a sufficient workforce of pediatric rheu-
matologists is eloquently described by a parent of a child
with dermatomyositis in a recent article in the Washing-
ton Post newspaper. [11]
I admit to my bias and passion. I believe in pediatric rheu-
matology and its mission. We have all seen an enormous
growth around the world of pediatric rheumatology with
many countries recognizing pediatric rheumatology and
aiding its development. But our work is only partially fin-
ished. For the benefit of children with arthritis diseases, I
hope that you will officially recognize pediatric rheuma-
tology in your country as a legitimate pediatric subspe-
cialty and that you will support its development.
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